Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

What can we learn from failed neuropathic pain trials?

Polydefkis M, Raja SN.

Neurology. 2008 Jan 22;70(4):250-1. doi: 10.1212/01.wnl.0000298088.76718.18. No abstract available.

PMID:
18209199
2.

Toward a definition of pharmacoresistant neuropathic pain.

Hansson PT, Attal N, Baron R, Cruccu G.

Eur J Pain. 2009 May;13(5):439-40. doi: 10.1016/j.ejpain.2009.02.008. Epub 2009 Mar 25. No abstract available.

PMID:
19324579
3.

Clinical trial outcome in neuropathic pain: relationship to study characteristics.

Katz J, Finnerup NB, Dworkin RH.

Neurology. 2008 Jan 22;70(4):263-72.

PMID:
17914067
4.

Pharmacotherapy for neuropathic pain.

Jackson KC 2nd.

Pain Pract. 2006 Mar;6(1):27-33. Review.

PMID:
17309706
5.

Mechanisms of neuropathic pain and their implications for the design of clinical trials.

Rowbotham MC.

Neurology. 2005 Dec 29;65(12 Suppl 4):S66-73. Review.

PMID:
16385106
6.

Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.

Dworkin RH, Katz J, Gitlin MJ.

Neurology. 2005 Dec 29;65(12 Suppl 4):S7-19. Review.

PMID:
16385107
7.

Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?

Vo T, Rice AS, Dworkin RH.

Pain. 2009 Jun;143(3):169-71. doi: 10.1016/j.pain.2009.03.013. Epub 2009 Apr 10. Review. No abstract available.

PMID:
19362418
8.

Pharmacologic management part 1: better-studied neuropathic pain diseases.

Backonja MM, Serra J.

Pain Med. 2004 Mar;5 Suppl 1:S28-47. Review.

PMID:
14996228
9.

Molecular mechanism of neuropathic pain.

Ueda H, Rashid MH.

Drug News Perspect. 2003 Nov;16(9):605-13. Review.

PMID:
14702142
10.

Neuropathic pain: evidence matters.

McQuay HJ.

Eur J Pain. 2002;6 Suppl A:11-8. Review.

PMID:
11888235
11.

Neural modulation by blocks and infusions.

Varrassi G, Paladini A, Marinangeli F, Racz G.

Pain Pract. 2006 Mar;6(1):34-8. Review.

PMID:
17309707
12.

Pharmacologic management part 2: lesser-studied neuropathic pain diseases.

Backonja MM, Serra J.

Pain Med. 2004 Mar;5 Suppl 1:S48-59. Review.

PMID:
14996229
13.

Neuropathic pain in leprosy.

Haanpää M, Lockwood DN, Hietaharju A.

Lepr Rev. 2004 Mar;75(1):7-18. Review.

PMID:
15072122
14.

Analgesic effect of milnacipran is associated with c-Fos expression in the anterior cingulate cortex in the rat neuropathic pain model.

Takeda R, Watanabe Y, Ikeda T, Abe H, Ebihara K, Matsuo H, Nonaka H, Hashiguchi H, Nishimori T, Ishida Y.

Neurosci Res. 2009 Aug;64(4):380-4. doi: 10.1016/j.neures.2009.04.010. Epub 2009 Apr 19.

PMID:
19383518
15.

Chronic neuropathic pain: mechanisms, drug targets and measurement.

Finnerup NB, Sindrup SH, Jensen TS.

Fundam Clin Pharmacol. 2007 Apr;21(2):129-36. Review.

PMID:
17391285
16.

Afterword: five steps to increase the payoff of chronic pain trials.

Max MB.

Neurology. 2005 Dec 29;65(12 Suppl 4):S74-7. No abstract available.

PMID:
16385108
17.

Emerging trends in the management of neuropathic pain.

McCleane G.

Expert Rev Neurother. 2005 Sep;5(5):617-23. Review.

PMID:
16162085
18.

Painful peripheral neuropathy and its nonsurgical treatment.

Wolfe GI, Trivedi JR.

Muscle Nerve. 2004 Jul;30(1):3-19. Review.

PMID:
15221874
19.

Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies.

Hansson PT, Dickenson AH.

Pain. 2005 Feb;113(3):251-4. Review. No abstract available.

PMID:
15661430
20.

The management of neuropathic pain in cancer: clinical guidelines for the use of adjuvant analgesics.

George RM, Ahmedzai SH.

Indian J Cancer. 2000 Mar;37(1):4-9. Review.

PMID:
11261235

Supplemental Content

Support Center